U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07905144) titled 'A Clinical Study Evaluating the Safety and Preliminary Effectiveness of Induced Pluripotent Stem Cell-derived Platelets in Patients With Thrombocytopenia Caused by Allogeneic Hematopoietic Stem Cell Transplantation' on Oct. 23.
Brief Summary: A multicenter open-label study with dose-escalation and multiple expansion cohorts, aimed at evaluating the safety and preliminary efficacy of IPSC-derived platelets in patients with thrombocytopenia caused by allogeneic hematopoietic stem cell transplantation.
Study Start Date: Dec. 30
Study Type: INTERVENTIONAL
Condition:
Thrombocytopenia
Intervention:
DRUG: iPSC-derived platelets
for ...